Iktos and Servier announce the success of their first collaboration, which was designed to evaluate Iktos technology’s potential to accelerate the discovery of promising new compounds in a real-life drug discovery project. The results of this collaboration were presented at the XXV EFMC International Symposium on Medicinal Chemistry held in Ljubljana, Slovenia from September 2 to 6, 2018. Servier and Iktos announce their intention to pursue their collaboration in the coming months, in line with Servier’s strategy to invest strongly in AI technologies for new drug discovery. Follow the link for the full press release.
